Skip to content
Saturday 22 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,816.56
+0.64%
DAX
26,136.56
+0.59%
CAC 40
8,484.43
+0.37%
STOXX 50
6,462.22
+0.63%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE

Product/Service

  • Cloudflare and Mastercard Partner to Extend Comprehensive Cyber Defense Across Critical Infrastructure and Small Businesses

    February 17, 2026

    Combined security offerings will uncover hidden risks, assess security posture, and automate defenses for all web-facing assets

  • Endava Partners with Miro to Drive Innovative New Model for AI Transformation

    February 17, 2026

    Strategic partnership embeds Miro AI platform across Endava's global offering to strengthen its AI-native delivery model

  • TNS Launches Market Data Usage Optimization Portal

    February 17, 2026

    Transaction Network Services (TNS) today announced an upgrade to its TNS Data Usage Optimizer (DUO) with the launch of an interactive customer portal. Building on the launch of DUO in late 2024, this new interface offers buy-side and sell-side firms direct, on-demand access to the DUO portal to analyze market data subscriptions, identify unused services, [...]

  • New ECCO data show subcutaneous (SC) infliximab (Remsima™  SC) effectively recaptures and maintains disease control after drug holiday

    February 16, 2026

    A new post-hoc analysis from the LIBERTY studies, presented at ECCO 2026, demonstrated that initiating subcutaneous (SC) infliximab (Remsima™ SC) after a treatment interruption following intravenous (IV) infliximab induction helps patients with Crohn’s disease (CD) and ulcerative colitis (UC) recapture and maintain disease control1 The results demonstrated that SC infliximab provides an effective and safe option to regain clinical control after a planned or unplanned treatment interruption More than a total of 30 accepted abstracts including one oral and one digital oral presentation and eight posters, reinforce Celltrion’s commitment to inflammatory bowel disease (IBD) research aimed at enhancing patient outcomes

  • HM King Mohammed VI Presides Over the Launch Ceremony of the Aircraft Landing Gear Production Plant Project, Representing an Investment of €280 million by the Safran Group in Morocco

    February 13, 2026

    His Majesty King Mohammed VI, may God assist Him, accompanied by HRH Crown Prince Moulay El Hassan, chaired on Friday at the Royal Palace in Casablanca the presentation and launch ceremony of the project to build a landing gear production factory for Safran in Nouaceur, a project that reinforces Morocco as a destination of choice [...]

  • Alipay AI Payment Exceeds 120 Million Transactions in One Week as Agentic Commerce Accelerates in China

    February 13, 2026

    Alipay announced that its AI Pay, a payment solution that enables secure and seamless payment through AI agents, exceeded 120 million transactions in the past week, as agentic commerce accelerates in China, making it the world’s first AI agentic payment service to reach this milestone. This press release features multimedia. View the full release here: [...]

  • Topcon Secures Early Access to Xona’s Pulsar Satellite Navigation Service

    February 12, 2026

    Topcon Positioning Systems has signed a commercial agreement with Xona to secure early-adopter access to Pulsar, Xona’s low Earth orbit (LEO) satellite navigation constellation. This agreement positions Topcon among Xona’s first commercial customers preparing to integrate Pulsar into future high-precision positioning workflows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212891607/en/ “The letter [...]

  • Expensify and Xero Enhance Partnership to Support Small Businesses

    February 12, 2026

    The new partnership offers customers Xero for free for six months and six months of Expensify for 50% off.

  • Zeon Corporation Makes Strategic Investment in Chemify to Accelerate Digital Chemistry Innovation and Drive Development of New Materials Through State-of-the-Art Automated Molecular Design and Synthesis

    February 12, 2026

    Partnership supports Chemify’s application of its Chemputation technology to design and make novel compounds and materials for Zeon

  • Stafford Capital Partners Announces New Renewable Energy Investment Strategy with Dedicated Team

    February 12, 2026

    Stafford Capital Partners integrates dedicated renewables team to strengthen the firm’s strategic infrastructure investing capabilities with a focus on energy transition opportunities.

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 75
  • Page 76
  • Page 77
  • Page 78
  • Page 79
  • …
  • Page 115
  • Next

Trending Articles

  • House prices in wealthy London boroughs fall by up to £300,000

  • Ratcliffe’s Ineos saves Runcorn plant

  • Amazon says it buys books in bulk to ‘improve products’

  • Mike Ashley’s Frasers offers to pay personal shoppers in Harvey Nichols takeover

  • As it happened: FTSE 100 rallies after JD Sports drags on blue chips; oil jumps again

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook